A 35-year-old emaciated male with a history of disseminated tuberculosis presents with the following features: BP = 85/60 mmHg, low volume pulse of 100 BPM, diffuse hyperpigmentation involving hand creases, serum Na+ = 120 meq/L, and serum K+ = 6.6 meq/L. What is your most immediate response?
A patient presented with the following serum parameters: Normal serum ALP, normal PTH level, and increased Ca+ and PO4. What is the most likely cause?
An elderly diabetic woman with chronic steroid-dependent bronchospasm has an ileocolectomy for a perforated cecum. She is taken to the ICU intubated and is maintained on broad-spectrum antibiotics, renal dose dopamine, and a rapid steroid taper. On postoperative day 2, she develops a fever of 39.2°C, hypotension, lethargy, and laboratory values remarkable for hypoglycemia and hyperkalemia. Which of the following is the most likely explanation for her deterioration?
A 35-year-old woman, on hemodialysis for chronic renal disease, complains of pain in the hands. On examination, the joints are normal with no inflammation or tenderness on palpation. Lab values reveal a low calcium, high phosphate, and high PTH level. What is the most likely diagnosis?
A 53-year-old female patient with a known history of osteoarthritis and diabetes, treated with metformin 500mg, sitagliptin, and glimepiride 1mg for 10 years, was recently diagnosed with chronic kidney disease (CKD) due to NSAID usage. What is the next step in her management regarding her diabetes and pain control?
A 50-year-old lady with a history of carcinoid syndrome complains of flushing and diarrhea. Which of the following statements is not true regarding this syndrome?
Hypokalemia with hypertension is seen in which condition?
Which of the following is not a feature of pseudohypoparathyroidism?
In thyrotoxicosis, which of the following is commonly seen?
Which of the following is a symptom of hypothyroidism?
Explanation: ### Explanation **1. Why Option C is Correct:** The patient presents with the classic triad of **Addisonian Crisis** (Acute Adrenocortical Insufficiency): **Refractory hypotension** (BP 85/60), **electrolyte imbalances** (hyponatremia and hyperkalemia), and **hyperpigmentation** [1]. * **Pathophysiology:** Disseminated tuberculosis is the leading cause of primary adrenal insufficiency in developing countries [2]. Destruction of the adrenal cortex leads to a deficiency of both cortisol and aldosterone. * **Clinical Correlation:** Lack of aldosterone causes sodium wasting (hyponatremia) and potassium retention (hyperkalemia) [1]. High ACTH levels (due to lack of negative feedback) cross-react with MSH receptors, causing hyperpigmentation (especially in creases and scars). * **Immediate Management:** This is a medical emergency. The priority is volume resuscitation and immediate administration of **IV Hydrocortisone** [1]. **2. Why Other Options are Incorrect:** * **Option A:** Secondary hyperaldosteronism involves *high* sodium and *low* potassium (the opposite of this case). Furthermore, secondary insufficiency (pituitary origin) does not cause hyperpigmentation. * **Option B:** While sepsis can cause hypotension, it does not typically present with diffuse hyperpigmentation or the specific electrolyte pattern of hyperkalemia unless associated with renal failure or Waterhouse-Friderichsen syndrome. * **Option D:** Pulmonary embolism causes hypotension and tachycardia but does not explain the hyperpigmentation or the specific electrolyte derangements (Na+ 120, K+ 6.6). **3. NEET-PG High-Yield Pearls:** * **Most common cause worldwide:** Autoimmune adrenalitis (Schmidt Syndrome). * **Most common cause in India:** Tuberculosis [2]. * **Gold Standard Test:** ACTH Stimulation Test (Cosyntropin test) [1]. * **Drug of Choice in Crisis:** IV Hydrocortisone (it has both glucocorticoid and mineralocorticoid activity) [1]. * **Electrolyte Hallmark:** Hyperkalemic Metabolic Acidosis with Hyponatremia [1].
Explanation: The biochemical profile of **increased Calcium (Ca²⁺)** and **increased Phosphate (PO₄³⁻)** with **normal Alkaline Phosphatase (ALP)** and **normal/low PTH** is characteristic of **Vitamin D intoxication**. **1. Why Vitamin D Intoxication is Correct:** Vitamin D (specifically 1,25-(OH)₂D) acts on the intestines to increase the absorption of both calcium and phosphate. It also promotes bone resorption [1]. In toxicity, the excessive levels lead to hypercalcemia and hyperphosphatemia. High serum calcium provides negative feedback to the parathyroid glands, resulting in **suppressed or low-normal PTH** [1]. Unlike bone-remodeling diseases, Vitamin D toxicity does not typically elevate ALP unless there is significant concurrent bone pathology. **2. Why the Other Options are Incorrect:** * **Hyperparathyroidism:** Characterized by high Ca²⁺ but **low PO₄³⁻** (due to PTH-induced phosphaturia [1]) and **elevated PTH**. ALP is often elevated in primary hyperparathyroidism (Osteitis fibrosa cystica). * **Osteoporosis:** A quantitative bone disorder where serum calcium, phosphate, PTH, and ALP levels typically remain **within the normal range**. * **Osteomalacia:** Characterized by defective mineralization, leading to **low or normal Ca²⁺ and PO₄³⁻** [2], and characteristically **elevated ALP** and secondary hyperparathyroidism (high PTH). **3. NEET-PG High-Yield Pearls:** * **ALP** is a marker of **osteoblast activity**. It is elevated whenever there is high bone turnover (e.g., Paget’s disease, Rickets, Bone metastasis). * **PTH vs. Vit D:** PTH increases Ca²⁺ but decreases PO₄³⁻ [1]. Vitamin D increases **both** Ca²⁺ and PO₄³⁻. * **Milk-Alkali Syndrome:** Another cause of hypercalcemia with high phosphate, but usually presents with metabolic alkalosis and a history of antacid ingestion. * **Sarcoidosis:** Can mimic Vitamin D intoxication because macrophages produce extra-renal 1-alpha-hydroxylase, increasing active Vitamin D levels.
Explanation: ### Explanation The correct answer is **Adrenal Insufficiency (Addisonian Crisis)**. **Why it is correct:** The patient has several risk factors for **Secondary Adrenal Insufficiency**: chronic steroid use (causing HPA axis suppression) and a "rapid steroid taper" during a period of extreme physiological stress (major surgery and sepsis). When a steroid-dependent patient faces stress, their body cannot mount the necessary cortisol response. The clinical triad of **refractory hypotension, fever, and altered mental status (lethargy)**, combined with classic biochemical markers—**hypoglycemia** (due to loss of cortisol's gluconeogenic effect) and **hyperkalemia**—strongly points to an adrenal crisis. **Why the other options are incorrect:** * **Sepsis:** While fever and hypotension are seen in sepsis, sepsis typically causes *hyperglycemia* (stress response) rather than hypoglycemia. Furthermore, the electrolyte pattern (hyperkalemia) is more specific to adrenal dysfunction in this context. * **Hypovolemia:** This would explain hypotension and lethargy but does not typically cause high-grade fever, hypoglycemia, or hyperkalemia. * **Acute Tubular Necrosis (ATN):** While ATN can cause hyperkalemia and follows hypotension, it does not explain the fever or the acute hypoglycemia. **NEET-PG High-Yield Pearls:** * **The "Rule of 2s" for HPA suppression:** Suspect suppression if a patient has taken **20 mg** of Prednisone (or equivalent) for **>2 weeks** in the last year. * **Electrolytes:** In *Primary* AI (Addison’s), you see hyperkalemia and hyponatremia (due to mineralocorticoid deficiency). In *Secondary* AI (Steroid withdrawal), mineralocorticoids are often spared by the RAAS, but hyperkalemia can still occur in acute crises due to severe metabolic shifts. * **Management:** Do not wait for ACTH stimulation test results. Treat immediately with **IV Hydrocortisone (100mg bolus)** and aggressive fluid resuscitation.
Explanation: ### Explanation **Correct Answer: C. Secondary hyperparathyroidism** **1. Why it is correct:** In patients with Chronic Kidney Disease (CKD) on hemodialysis, the kidneys fail to excrete phosphate and cannot convert Vitamin D to its active form (1,25-dihydroxyvitamin D). This leads to **Hyperphosphatemia** and **Hypocalcemia**. The low serum calcium and low Vitamin D levels act as potent stimuli for the parathyroid glands, leading to compensatory hyperplasia and excessive secretion of **Parathyroid Hormone (PTH)** [1,2]. This physiological response to an external stimulus (hypocalcemia) is termed **Secondary Hyperparathyroidism**. The "pain in the hands" in this context is likely due to **Renal Osteodystrophy** (specifically osteitis fibrosa cystica), where high PTH causes subperiosteal bone resorption, commonly seen in the phalanges [1]. **2. Why other options are incorrect:** * **Scleroderma (A):** While it causes hand pain/tightness, it typically presents with skin thickening, Raynaud’s phenomenon, and telangiectasia. It does not explain the specific triad of low Ca, high PO4, and high PTH. * **Gout (B):** This is an inflammatory arthritis caused by monosodium urate crystals. It presents with acute, severe inflammation (redness, warmth, swelling), which is absent in this patient. * **Pseudogout (D):** Caused by calcium pyrophosphate deposition. Like gout, it presents with acute inflammatory arthritis. While it can be associated with hyperparathyroidism, the biochemical profile provided is the classic "textbook" description of secondary hyperparathyroidism [2]. **3. NEET-PG High-Yield Pearls:** * **Tertiary Hyperparathyroidism:** Occurs when long-standing secondary HPT leads to autonomous PTH secretion, resulting in **High Calcium** and **High PTH** [1]. * **Radiology Sign:** Look for **subperiosteal resorption** on the radial side of the middle phalanges—a pathognomonic sign of hyperparathyroidism. * **Rugger-Jersey Spine:** A classic radiological feature of renal osteodystrophy (sclerosis of vertebral endplates). * **Management:** Treatment involves phosphate binders (e.g., Sevelamer), Vitamin D analogues (Calcitriol), and Calcimimetics (Cinacalcet).
Explanation: This question tests the clinical management of diabetes in the setting of progressive Chronic Kidney Disease (CKD) and the avoidance of nephrotoxic agents. ### **Explanation of the Correct Answer** The correct answer is **D (All of the above)** because the patient’s newly diagnosed CKD necessitates a complete overhaul of her current regimen: 1. **Metformin & Glimepiride:** Metformin is contraindicated when the eGFR falls below 30 mL/min due to the risk of lactic acidosis. Sulfonylureas (Glimepiride) increase the risk of prolonged, severe hypoglycemia in CKD as their metabolites are renally excreted. Transitioning to **Subcutaneous Insulin** is the safest and most effective way to manage glycemic control in advanced CKD. [1] 2. **Sitagliptin vs. Linagliptin:** While most DPP-4 inhibitors require dose adjustment in CKD, **Linagliptin** is unique because it is primarily excreted via the enterohepatic route (bile). It requires no dose adjustment regardless of renal function, making it the preferred oral agent. [1] 3. **Pain Management:** The patient’s CKD was likely precipitated or worsened by **NSAIDs**. These must be discontinued immediately to prevent further decline in GFR. For chronic pain like osteoarthritis in CKD, **Opioids** (specifically those with non-renal clearance like Fentanyl or Buprenorphine, or cautious use of Tramadol) are preferred over NSAIDs. ### **Why individual options are part of the "All of the above" strategy:** * **Option A:** Correct because Linagliptin is the "kidney-safe" DPP-4 inhibitor. * **Option B:** Correct because Metformin is hazardous in renal failure and insulin provides the most predictable control. [1] * **Option C:** Correct because NSAIDs are the primary nephrotoxin in this case and must be replaced with non-nephrotoxic analgesics. ### **NEET-PG High-Yield Pearls** * **Drug of Choice (DOC) for Diabetes in CKD:** Insulin. * **DPP-4 Inhibitor requiring NO renal adjustment:** Linagliptin (Mnemonic: **L**inagliptin **L**eaves via the **L**iver). * **Metformin Cut-offs:** Review eGFR; stop if <30 mL/min/1.73m², do not start if <45 mL/min/1.73m². [1] * **NSAID Mechanism in CKD:** They inhibit prostaglandins, leading to afferent arteriolar vasoconstriction and reduced renal perfusion.
Explanation: The correct answer is **D** because it describes a clinical feature that is characteristic of **gastric carcinoids**, not ileal carcinoids. 1. **Why Option D is the correct (false) statement:** In carcinoid syndrome, the type of flushing provides a clue to the tumor's origin. **Ileal (midgut) carcinoids** typically present with a **cyanotic, dusky-red, or violaceous flush** that involves the face and neck. In contrast, **bright-red, patchy, geographic flushing** is characteristic of **gastric (foregut) carcinoids**, often triggered by histamine release. 2. **Analysis of other options:** * **Option A:** Carcinoid crisis is a life-threatening complication characterized by profound hypotension or hypertension and arrhythmias. It is rare, occurring in **<10%** of patients, usually during induction of anesthesia or tumor manipulation. * **Option B:** **Octreotide** (a somatostatin analog) is the first-line medical management. It inhibits the release of serotonin and other vasoactive peptides, effectively controlling flushing and diarrhea. * **Option C:** Classic triggers for mediator release in carcinoid syndrome include **stress, alcohol consumption, and large meals** (due to the release of gastrin or catecholamines). **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** The best initial screening test is **24-hour urinary 5-HIAA** (a metabolite of serotonin). * **Localization:** **Somatostatin receptor scintigraphy (OctreoScan)** or Ga-68 DOTATATE PET/CT are the imaging modalities of choice [1]. * **Cardiac Involvement:** Carcinoid heart disease typically affects the **right side** (Tricuspid Regurgitation and Pulmonary Stenosis) because the lungs contain monoamine oxidase (MAO) which inactivates serotonin before it reaches the left heart [1]. * **Pellagra Connection:** Chronic serotonin overproduction can lead to **Niacin (Vitamin B3) deficiency**, as tryptophan is diverted away from niacin synthesis toward serotonin synthesis.
Explanation: **Explanation:** The combination of **hypertension and hypokalemia** is a classic clinical marker for states of mineralocorticoid excess. **1. Why Primary Hyperaldosteronism is correct:** In Primary Hyperaldosteronism (Conn’s Syndrome), autonomous secretion of aldosterone from the adrenal cortex leads to excessive stimulation of the ENaC channels in the renal distal tubule and collecting duct. This results in: * **Sodium retention and water reabsorption:** Leading to volume expansion and **hypertension**. * **Potassium excretion:** Leading to **hypokalemia**. * **Hydrogen ion excretion:** Leading to metabolic alkalosis. Notably, because of the volume expansion, plasma renin activity is suppressed. **2. Why the other options are incorrect:** * **Bartter Syndrome:** This is a "salt-wasting" tubulopathy (defect in the thick ascending limb). While it causes hypokalemia and metabolic alkalosis, it is characterized by **normotension or hypotension** due to chronic volume depletion and activated renin-angiotensin system. * **Primary Hyperparathyroidism:** This condition is characterized by hypercalcemia and hypophosphatemia. It is not typically associated with hypokalemia. * **Diuretic Therapy:** While loop and thiazide diuretics commonly cause **hypokalemia**, they are used to treat hypertension and generally result in **lower blood pressure**, not hypertension (unless the patient has underlying poorly controlled HTN). **NEET-PG High-Yield Pearls:** * **Screening Test:** Aldosterone-to-Renin Ratio (ARR). A high ratio (>20-30) suggests primary hyperaldosteronism. * **Liddle Syndrome:** A rare genetic cause of hypertension + hypokalemia that mimics hyperaldosteronism but presents with **low aldosterone** levels (Pseudohyperaldosteronism). * **Licorice Ingestion:** Can cause hypertension and hypokalemia by inhibiting the enzyme 11β-HSD2, allowing cortisol to act on mineralocorticoid receptors.
Explanation: Explanation: Pseudohypoparathyroidism (PHP) is a genetic disorder characterized by target organ resistance to Parathyroid Hormone (PTH) [1]. The primary defect lies in the Gsα subunit of the G protein-coupled receptor [3], which prevents PTH from activating its downstream signaling pathway. 1. Why "Hypoparathyroidism" is the correct answer: In PHP, the parathyroid glands are functioning normally, but the body cannot respond to the hormone. Because the kidneys and bones are "deaf" to PTH, the body perceives a deficiency. In response, the parathyroid glands undergo hyperplasia and secrete excessive PTH to compensate. Therefore, patients have Hyperparathyroidism (biochemically), not Hypoparathyroidism [1]. 2. Analysis of Incorrect Options: * Hypocalcemia (B): Since the kidneys cannot respond to PTH, there is decreased calcium reabsorption and impaired Vitamin D activation, leading to low serum calcium [1]. * Hyperphosphatemia (D): PTH normally promotes phosphate excretion (phosphaturia) [2]. Resistance to PTH leads to phosphate retention, resulting in high serum phosphate [1]. * Hyperparathyroidism (A): As explained above, low calcium levels trigger a feedback loop that causes a secondary rise in PTH levels [2]. NEET-PG High-Yield Pearls: * Albright’s Hereditary Osteodystrophy (AHO): A phenotypic presentation of PHP Type 1a featuring short stature, round face, obesity, and shortened 4th and 5th metacarpals [1]. * Pseudopseudohypoparathyroidism (PPHP): Patients have the AHO phenotype but normal biochemical levels (Calcium, Phosphate, and PTH are all normal) because the defect is inherited paternally [1]. * Biochemical Hallmark: High PTH + Low Calcium + High Phosphate.
Explanation: In thyrotoxicosis, particularly when caused by Graves' disease, multisystem involvement leads to a variety of clinical manifestations. [2] **Explanation of Options:** * **Pretibial Myxedema (Thyroid Dermopathy):** This is a specific autoimmune manifestation of Graves' disease. It occurs due to the accumulation of glycosaminoglycans (hyaluronic acid) in the dermis, triggered by TSH-receptor antibodies. [2] While it occurs in only 1–5% of patients, it is a classic finding associated with thyrotoxicosis. [1] * **Glycosuria:** Thyrotoxicosis is a "diabetogenic" state. Excess thyroid hormone increases glucose absorption from the gut, accelerates glycogenolysis, and enhances gluconeogenesis. [4] This often leads to postprandial hyperglycemia that exceeds the renal threshold, resulting in glucose in the urine. * **Unilateral Exophthalmos:** While Graves' ophthalmopathy is typically bilateral, it is frequently **asymmetric**. In fact, Graves' disease is the **most common cause of both bilateral and unilateral exophthalmos** in adults. **Why "All of the above" is correct:** Thyrotoxicosis encompasses both the metabolic effects of excess T4/T3 (leading to glycosuria) and the autoimmune associations of Graves' disease (dermopathy and ophthalmopathy). [4] Since all three features can be clinical components of the syndrome, Option D is the most accurate. **High-Yield NEET-PG Pearls:** * **Most common cause of thyrotoxicosis:** Graves' Disease. [4] * **Thyroid Acropachy:** A rare triad of clubbing, periosteal proliferation, and soft tissue swelling seen in severe Graves' disease. * **Cardiac sign:** High-output heart failure and atrial fibrillation are common in elderly patients (Apathetic Hyperthyroidism). [3] * **Stellwag’s sign:** Infrequent or incomplete blinking seen in thyrotoxicosis.
Explanation: **Explanation:** Hypothyroidism is a clinical syndrome resulting from a deficiency of thyroid hormones (T3 and T4), leading to a generalized slowing of metabolic processes [1]. **Why Hair Loss is Correct:** Thyroid hormones are essential for the initiation of the anagen (growth) phase of the hair cycle. In hypothyroidism, hair follicles enter the telogen (resting) phase prematurely, leading to diffuse **alopecia** and thinning of the hair. A classic high-yield sign is **Madarosis**—the loss of the outer one-third of the eyebrows. Additionally, decreased sebum production makes the hair dry, brittle, and coarse. **Analysis of Incorrect Options:** * **A. Hyperactivity:** Hypothyroidism causes psychomotor retardation, lethargy, and "myxedema madness" (slowing of mental processes), whereas hyperactivity is a hallmark of hyperthyroidism. * **B. Palpitation:** This is a symptom of increased sympathetic activity and tachycardia seen in hyperthyroidism [2]. Hypothyroidism typically presents with **bradycardia** and decreased cardiac output. * **C. Diarrhoea:** Hypothyroidism leads to decreased gastrointestinal motility, resulting in **constipation**. Frequent bowel movements or diarrhea are characteristic of hyperthyroidism. **NEET-PG High-Yield Pearls:** * **Most common cause:** Hashimoto’s Thyroiditis (autoimmune) in iodine-sufficient areas. * **Key metabolic feature:** Weight gain despite poor appetite and **cold intolerance**. * **Neuromuscular sign:** Delayed relaxation of deep tendon reflexes (Woltman sign) [1]. * **Dermatological feature:** Non-pitting edema (Myxedema) due to glycosaminoglycan deposition in the dermis.
Diabetes Mellitus
Practice Questions
Thyroid Disorders
Practice Questions
Adrenal Gland Disorders
Practice Questions
Pituitary Disorders
Practice Questions
Calcium and Bone Metabolism
Practice Questions
Reproductive Endocrinology
Practice Questions
Lipid Disorders
Practice Questions
Endocrine Hypertension
Practice Questions
Multiple Endocrine Neoplasia
Practice Questions
Obesity and Metabolic Syndrome
Practice Questions
Neuroendocrine Tumors
Practice Questions
Endocrine Emergencies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free